ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATYR ATYR PHARMA INC

盘后交易 03-16 16:01:50 EDT

0.8945

+0.0445

+5.24%

盘后0.8901

-0.0044-0.49%

16:01 EDT

最高0.8999	最低0.8410	成交量94.90万
今开0.8500	昨收0.8500	日振幅6.93%
总市值8,765万	流通市值8,584万	总股本9,799万
成交额83.31万	换手率0.99%	流通股本9,597万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":0.8945,"timestamp":1773691200000,"preClose":0.85,"halted":0,"volume":949017,"hourTrading":{"tag":"盘后","latestPrice":0.8901,"preClose":0.8945,"latestTime":"16:01 EDT","volume":3339,"amount":2986.07561343,"timestamp":1773691265285,"change":-0.0044,"changeRate":-0.004919,"amplitude":0.004919},"delay":0,"changeRate":0.05235294117647057,"floatShares":95966000,"shares":97986634,"eps":-0.797093,"marketStatus":"盘后交易","change":0.0445,"latestTime":"03-16 16:01:50 EDT","open":0.85,"high":0.8999,"low":0.841,"amount":833135.238828,"amplitude":0.069294,"askPrice":1,"askSize":1500,"bidPrice":0.85,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.797093,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773705600000},"marketStatusCode":4,"adr":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":0.85,"preHourTrading":{"tag":"盘前","latestPrice":0.8578,"preClose":0.85,"latestTime":"09:25 EDT","volume":2046,"amount":1763.299065,"timestamp":1773667500012,"change":0.0078,"changeRate":0.009176,"amplitude":0.014235},"postHourTrading":{"tag":"盘后","latestPrice":0.8901,"preClose":0.8945,"latestTime":"16:01 EDT","volume":3339,"amount":2986.07561343,"timestamp":1773691265285,"change":-0.0044,"changeRate":-0.004919,"amplitude":0.004919},"volumeRatio":0.910576,"impliedVol":3.2574,"impliedVolPercentile":0.8645},"requestUrl":"/m/hq/s/ATYR","defaultTab":"news","newsList":[{"id":"2609154675","title":"Atyr Pharma, Inc.盘中异动 快速拉升5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609154675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609154675?lang=zh_cn&edition=full","pubTime":"2026-02-07 03:11","pubTimestamp":1770405114,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日03时11分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.71%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207031155a6dcaa07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207031155a6dcaa07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"1178762224","title":"ATYR PHARMA INC 宣布安排与美国FDA进行C类会议，讨论Efzofitimod治疗肺结节病项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1178762224","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178762224?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:03","pubTimestamp":1770123813,"startTime":"0","endTime":"0","summary":"ATYR PHARMA INC 已正式安排与美国食品药品监督管理局（FDA）举行C类会议，重点讨论其候选药物Efzofitimod在肺结节病领域的研发项目。此次会议旨在就该项目的关键开发路径与监管机构进行深入交流。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2586418212","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.00%报0.698美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586418212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586418212?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:33","pubTimestamp":1763994800,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时33分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报0.698美元/股，成交量5.4894万股，换手率0.06%，振幅4.50%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223321977cabaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223321977cabaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","ATYR","BK4139"],"gpt_icon":0},{"id":"2585317922","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.16%报0.685美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585317922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585317922?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:54","pubTimestamp":1763747667,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时54分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.16%。截至发稿，该股报0.685美元/股，成交量119.212万股，换手率1.22%，振幅6.75%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015428a7098337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015428a7098337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2579210685","title":"Atyr Pharma, Inc.盘中异动 下午盘股价大跌5.02%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579210685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579210685?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:14","pubTimestamp":1761848097,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日02时14分，Atyr Pharma, Inc.股票出现异动，股价大幅跳水5.02%。截至发稿，该股报0.920美元/股，成交量238.338万股，换手率2.43%，振幅4.15%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103102145894e5f739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103102145894e5f739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2569974629","title":"Atyr Pharma, Inc.盘中异动 临近收盘快速下跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569974629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569974629?lang=zh_cn&edition=full","pubTime":"2025-09-24 03:56","pubTimestamp":1758657380,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日03时56分，Atyr Pharma, Inc.股票出现异动，股价急速下挫6.05%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.30%。其相关个股中，木薯科学、Surrozen Inc C/Wts 01/08/2031 、Galecto, Inc.涨幅较大，Galecto, Inc.、Silo Pharma, Inc.、Soligenix, Inc.较为活跃，换手率分别为4050.45%、360.01%、184.71%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、木薯科学、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为68.73%、48.49%、48.46%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924035620a6999ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924035620a6999ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"1137305404","title":"异动解读 | ATYR制药公司股价夜盘大涨23.15%后暴跌81.8%，肺病新药试验失败","url":"https://stock-news.laohu8.com/highlight/detail?id=1137305404","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137305404?lang=zh_cn&edition=full","pubTime":"2025-09-16 08:02","pubTimestamp":1757980947,"startTime":"0","endTime":"0","summary":"ATYR制药公司股价在夜盘交易中大涨23.15%后，周一盘中遭遇重创，暴跌81.8%至1.09美元的历史新低。这种剧烈的价格波动源于该公司最新公布的临床试验结果。ATYR制药公司周一宣布，其用于治疗肺肉瘤病的新药efzofitimod在一项后期临床研究中未能达到主要终点。该试验旨在证明，与安慰剂相比，使用efzofitimod的患者在48周后每日类固醇用量的削减幅度更大。这一令人失望的结果对ATYR制药公司的前景造成了严重打击。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ATYR"],"gpt_icon":1},{"id":"1122596588","title":"aTyr Pharma Inc：Leerink Partners将评级从跑赢大盘下调至与大盘持平，目标价从16美元下调至1美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122596588","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122596588?lang=zh_cn&edition=full","pubTime":"2025-09-15 23:33","pubTimestamp":1757950396,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc：Leerink Partners将评级从跑赢大盘下调至与大盘持平，目标价从16美元下调至1美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"1125274879","title":"异动解读 | aTyr Pharma股价盘前暴跌79.77%，肺病新药后期试验未达主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1125274879","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125274879?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:30","pubTimestamp":1757939424,"startTime":"0","endTime":"0","summary":"周一盘前交易中，生物制药公司aTyr Pharma股价大幅下跌79.77%，投资者对公司核心产品研发失利反应强烈。根据公司最新公告，aTyr Pharma的实验性药物efzofitimod在针对肺肉瘤病患者的后期临床试验中未能达到主要目标。尽管试验结果不尽如人意，但aTyr Pharma表示，efzofitimod的安全性与先前的研究结果一致。目前，已获批准的肺肉瘤病一线治疗方法主要是皮质类固醇激素，如泼尼松。aTyr Pharma此次研发失利，无疑打击了市场对公司开发新型治疗方案的期待，从而导致股价大幅下挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ATYR"],"gpt_icon":0},{"id":"1193378701","title":"aTyr Pharma宣布Efzofitimod治疗肺结节病的第3期Efzo-Fit™研究顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1193378701","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193378701?lang=zh_cn&edition=full","pubTime":"2025-09-15 19:30","pubTimestamp":1757935859,"startTime":"0","endTime":"0","summary":"aTyr Pharma宣布Efzofitimod治疗肺结节病的第3期Efzo-Fit™研究顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2566997849","title":"Atyr Pharma, Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566997849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566997849?lang=zh_cn&edition=full","pubTime":"2025-09-11 23:19","pubTimestamp":1757603947,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日23时19分，Atyr Pharma, Inc.股票出现波动，股价急速上涨5.15%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Maze Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Silexion Therapeutics Corp、Gri Bio, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为2251.40%、2183.07%、199.90%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Gri Bio, Inc.，振幅分别为155.42%、72.91%、58.33%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911231907a71c4cd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911231907a71c4cd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2518227987","title":"Atyr Pharma, Inc.盘中异动 大幅跳水5.15%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227987?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615271,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分，Atyr Pharma, Inc.股票出现波动，股价大幅跳水5.15%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3125.10%、665.08%、307.84%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022011196403dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022011196403dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2517165552","title":"Atyr Pharma, Inc.盘中异动 早盘急速跳水5.40%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165552?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:35","pubTimestamp":1741271727,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时35分，Atyr Pharma, Inc.股票出现异动，股价大幅下跌5.40%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Plus Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aeon Biopharma, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1013.38%、153.21%、52.21%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为24.20%、23.83%、23.12%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223527963c4da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223527963c4da0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2517107739","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.28%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517107739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517107739?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185126,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Atyr Pharma, Inc.股票出现波动，股价急速上涨5.28%。截至发稿，该股报3.19美元/股，成交量18.6199万股，换手率0.22%，振幅0.99%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206989d4604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206989d4604&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2516630867","title":"Atyr Pharma, Inc.盘中异动 早盘股价大跌5.44%报3.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630867?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:13","pubTimestamp":1741014780,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时13分，Atyr Pharma, Inc.股票出现波动，股价大幅下跌5.44%。截至发稿，该股报3.74美元/股，成交量17.4567万股，换手率0.21%，振幅6.19%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231300abe640c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231300abe640c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2514470018","title":"Atyr Pharma, Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514470018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514470018?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:03","pubTimestamp":1740495794,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时03分，Atyr Pharma, Inc.股票出现异动，股价急速下挫5.22%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。其相关个股中，Silexion Therapeutics Corp、Lava Therapeutics N.V.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为997.49%、572.79%、502.27%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts ，振幅分别为46.65%、43.70%、42.76%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230314962ffa0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230314962ffa0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2513727077","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727077?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:51","pubTimestamp":1740408694,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时51分，Atyr Pharma, Inc.股票出现异动，股价急速跳水5.56%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为128.96%、54.25%、24.94%，振幅较大的相关个股有Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Vaxart, Inc. - Common Stock，振幅分别为137.23%、41.14%、21.42%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225134abdb12cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225134abdb12cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2513999022","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513999022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513999022?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:00","pubTimestamp":1740150054,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时00分，Atyr Pharma, Inc.股票出现波动，股价急速拉升5.19%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为110.59%、90.12%、29.67%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、35.45%、33.83%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230054a24eb7c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230054a24eb7c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2512748821","title":"Atyr Pharma, Inc.盘中异动 急速上涨5.01%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512748821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512748821?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975486,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.01%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为205.66%、202.13%、65.55%，振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、2Seventy Bio, Inc.，振幅分别为21.86%、11.29%、7.53%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223126988b3144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223126988b3144&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2512653971","title":"Atyr Pharma, Inc.盘中异动 早盘股价大涨5.22%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512653971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512653971?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Atyr Pharma, Inc.股票出现异动，股价大幅上涨5.22%。截至发稿，该股报3.59美元/股，成交量6.2845万股，换手率0.07%，振幅0.00%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223113a24aac55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223113a24aac55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":0.0316},{"period":"1month","weight":-0.0829},{"period":"3month","weight":0.0961},{"period":"6month","weight":-0.859},{"period":"1year","weight":-0.787},{"period":"ytd","weight":0.0854}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于基于tRNA合成酶生物学开发治疗纤维化和炎症的疗法。其主要候选药物efzofitimod是一种新型免疫调节剂，正在研究用于治疗间质性肺病，包括肺结节病和系统性硬化症相关间质性肺病。","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.035951},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.011862},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.062074},{"month":4,"riseRate":0.3,"avgChangeRate":-0.032312},{"month":5,"riseRate":0.5,"avgChangeRate":-0.058101},{"month":6,"riseRate":0.545455,"avgChangeRate":-0.018872},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.001577},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.059775},{"month":9,"riseRate":0.454545,"avgChangeRate":0.014241},{"month":10,"riseRate":0.363636,"avgChangeRate":0.029504},{"month":11,"riseRate":0.545455,"avgChangeRate":0.024303},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.061175}],"exchange":"NASDAQ","name":"ATYR PHARMA INC","nameEN":"ATYR PHARMA INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ATYR PHARMA INC,ATYR,ATYR PHARMA INC股票,ATYR PHARMA INC股票老虎,ATYR PHARMA INC股票老虎国际,ATYR PHARMA INC行情,ATYR PHARMA INC股票行情,ATYR PHARMA INC股价,ATYR PHARMA INC股市,ATYR PHARMA INC股票价格,ATYR PHARMA INC股票交易,ATYR PHARMA INC股票购买,ATYR PHARMA INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}